168 related articles for article (PubMed ID: 9856520)
1. High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients.
Coyne DW; Dagogo-Jack S; Klein S; Merabet E; Audrain J; Landt M
Am J Kidney Dis; 1998 Dec; 32(6):1031-5. PubMed ID: 9856520
[TBL] [Abstract][Full Text] [Related]
2. Effect of formaldehyde/bleach reprocessing on in vivo performances of high-efficiency cellulose and high-flux polysulfone dialyzers.
Murthy BV; Sundaram S; Jaber BL; Perrella C; Meyer KB; Pereira BJ
J Am Soc Nephrol; 1998 Mar; 9(3):464-72. PubMed ID: 9513910
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W
Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334
[TBL] [Abstract][Full Text] [Related]
4. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
5. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
6. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory response of a new synthetic dialyzer membrane. A randomised cross-over comparison between polysulfone and helixone.
Stefoni S; Colì L; Cianciolo G; Donati G; Ruggeri G; Ramazzotti E; Pohlmeier R; Lang D
Int J Artif Organs; 2003 Jan; 26(1):26-32. PubMed ID: 12602466
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
9. Dialyzer-dependent changes in solute and water permeability with bleach reprocessing.
Scott MK; Mueller BA; Sowinski KM; Clark WR
Am J Kidney Dis; 1999 Jan; 33(1):87-96. PubMed ID: 9915272
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin concentrations in patients on hemodialysis.
Nakazono H; Nagake Y; Ichikawa H; Makino H
Nephron; 1998 Sep; 80(1):35-40. PubMed ID: 9730700
[TBL] [Abstract][Full Text] [Related]
11. Bisphenol A in chronic kidney disease.
Krieter DH; Canaud B; Lemke HD; Rodriguez A; Morgenroth A; von Appen K; Dragoun GP; Wanner C
Artif Organs; 2013 Mar; 37(3):283-90. PubMed ID: 23145999
[TBL] [Abstract][Full Text] [Related]
12. The Choice of Hemodialysis Membrane Affects Bisphenol A Levels in Blood.
Bosch-Panadero E; Mas S; Sanchez-Ospina D; Camarero V; Pérez-Gómez MV; Saez-Calero I; Abaigar P; Ortiz A; Egido J; González-Parra E
J Am Soc Nephrol; 2016 May; 27(5):1566-74. PubMed ID: 26432902
[TBL] [Abstract][Full Text] [Related]
13. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
McCarthy JT; Jenson BM; Squillace DP; Williams AW
Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
[TBL] [Abstract][Full Text] [Related]
14. Rebound kinetics of beta2-microglobulin after hemodialysis.
Leypoldt JK; Cheung AK; Deeter RB
Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease.
Touchette MA; Patel RV; Anandan JV; Dumler F; Zarowitz BJ
Am J Kidney Dis; 1995 Sep; 26(3):469-74. PubMed ID: 7645555
[TBL] [Abstract][Full Text] [Related]
16. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
Krieter DH; Lemke HD; Wanner C
Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
[TBL] [Abstract][Full Text] [Related]
17. Assessment of subjective and hemodynamic tolerance of different high- and low-flux dialysis membranes in patients undergoing chronic intermittent hemodialysis: a randomized controlled trial.
Bianchi G; Salvadé V; Lucchini B; Schätti-Stählin S; Salvadé I; Burnier M; Gabutti L
Hemodial Int; 2014 Oct; 18(4):825-34. PubMed ID: 24865782
[TBL] [Abstract][Full Text] [Related]
18. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers.
van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ
Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
Mudge DW; Rogers R; Hollett P; Law B; Reiger K; Petrie JJ; Price L; Johnson DW; Campbell SB; Isbel NM; Sullivan M; Hawley CM
Nephrol Dial Transplant; 2005 Oct; 20(10):2178-85. PubMed ID: 16030045
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of polysulfone and polyester-polymer alloy dialyzers on glycemic control in diabetic patients undergoing hemodialysis.
Abe M; Okada K; Maruyama T; Ikeda K; Kikuchi F; Kaizu K; Matsumoto K
Clin Nephrol; 2009 May; 71(5):514-20. PubMed ID: 19473611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
